bioaccess® and Amavita Research Services LLC are sister organizations under common ownership and leadership. While bioaccess® delivers U.S.-anchored regulatory strategy and Latin American trial execution, Amavita Research Services operates a dedicated clinical research site in Miami, Florida, conducting medical device and early-feasibility studies. Together they give sponsors both a U.S.-based, owner-operated research site and a 10-country Latin American execution network.
Julio G. Martinez-Clark serves as Chief Executive Officer of bioaccess® and Head of Growth & Strategy at Amavita Research Services LLC.